Ultragenyx Pharma (RARE) Posts Smaller-than-Expected Q2 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. MRNA
7. CSX
8. SPCX
9. WDC
10. QGEN

Go back to Ultragenyx Pharma (RARE) Posts Smaller-than-Expected Q2 Loss

Ultragenyx Pharma (RARE) PT Raised to $80 at Wedbush

August 6, 2018 7:50 AM EDT

Wedbush raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $80.00 (from $71.00) while maintaining a Outperform rating.

... More

Ultragenyx Pharma (RARE) PT Raised to $90 at Stifel

August 3, 2018 9:35 AM EDT

Stifel raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $90.00 (from $77.00) while maintaining a Buy rating.

... More

Ultragenyx Pharma (RARE) PT Raised to $85 at Piper Jaffray

August 3, 2018 6:01 AM EDT

Piper Jaffray raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $85.00 (from $67.00) while maintaining a Overweight rating.

... More